Overview

Neratinib, supplied as Hernix 40mg tablets in a 180-tablet pack, is an irreversible pan-HER tyrosine kinase inhibitor prescribed in the extended adjuvant setting for adults with early-stage HER2-positive breast cancer. Its commercial differentiator is covalent, time-dependent blockade of the HER receptor family, which sustains pathway suppression longer than reversible inhibitors that dissociate as plasma levels fall.

How It Works

The molecule forms a covalent bond at the ATP-binding site of EGFR, HER2, and HER4, locking the kinase in an inactive state. Because the bond persists until the protein is degraded, signaling through downstream growth pathways remains suppressed between doses. This mechanism underpins the extended-adjuvant strategy: continuous low-level blockade is intended to reduce late recurrence risk after trastuzumab-based therapy.

Indications

The 180-tablet pack supports the full course used in extended adjuvant treatment following prior HER2-directed therapy. Selection depends on HER2 status confirmed by validated assay and the patient's prior treatment history. Procurement should track lot expiry carefully because the long daily course spans many weeks.

Dosage & Administration

Standard use is one 40mg tablet taken orally once daily with food, together with prophylactic loperamide to reduce the high incidence of early diarrhea. The 180-count pack is sized for the prescribed window; distributors should align stock rotation with the typical course length to minimize expired inventory.

Storage & Sourcing

Maintain the tablets at 2–8°C and protect them from moisture; cold-chain handling during transit preserves potency. Source from authorized suppliers providing a COA and intact cold-chain evidence. GIVE LIFE TIME International supplies verified batches with temperature-log documentation for clinical channels.

Plan replenishment around the 180-tablet course length so stock turns before expiry. Confirm the pack carries the correct expiry for the planned course before dispatch to limit write-offs. Distributors should validate that the shipping carton maintains the required range across the expected transit time, and they should keep a temperature log at every handoff to protect both potency and regulatory standing. For multi-country distribution, verify that labelling and insert language meet each destination's requirements before the batch is released.

FAQ

Q: What makes neratinib different from reversible HER2 inhibitors?
It binds covalently to the kinase, so suppression continues after plasma levels drop between doses.

Q: Why is prophylactic loperamide used with this tablet?
Early diarrhea is common, and scheduled loperamide reduces its severity during the first weeks.

Q: How should the 40mg×180 pack be transported?
Keep it at 2–8°C with a documented cold chain from dispatch to receipt.